Hypomelanotic Disorder
Symptoms, Doctors, Treatments, Advances & More

Hypomelanotic Disorder Overview

Save information for later
Sign Up

Learn About Hypomelanotic Disorder

What is the definition of Hypomelanotic Disorder?
Hypomelanotic disorder is a term that refers to types of skin conditions in which melanocytes (pigment cells) have a loss of pigment. Types of hypomelanotic disorders include vitiligo, ash leaf spots, and idiopathic guttate hypomelanosis, among others.
What are the symptoms of Hypomelanotic Disorder?
Symptoms of hypomelanotic disorders include loss of pigmentation that varies by the type of disorder. Symptoms of vitiligo include a complete loss of pigment in the skin that appears as well-delineated spots and patches. Symptoms of ash leaf spots include oval flattened areas of skin that lack pigment and angiofibromas on the face. Symptoms of idiopathic guttate hypomelanosis include small white flattened areas on sun-exposed skin areas.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hypomelanotic Disorder?
Treatment for hypomelanotic disorders depends on the type. Treatment for vitiligo may include corticosteroids, tacrolimus, pimecrolimus, ultraviolet B and PUVA therapy, self-tanning creams, and skin grafting. Treatment for ash leaf spots may include laser therapy. Treatment for idiopathis guttate hypomelanosis is not necessary.
Who are the top Hypomelanotic Disorder Local Doctors?
Elite in Hypomelanotic Disorder
Dr. Amit G. Pandya
Dermatology
Elite in Hypomelanotic Disorder
Dr. Amit G. Pandya
Dermatology
Referral may be required

Sunnyvale Center (401)

401 Old San Francisco Road, Level 2, 
Sunnyvale, CA 
650-934-7676
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Amit Pandya is a Dermatologist practicing medicine in Sunnyvale, California. Dr. Pandya is rated as an Elite provider by MediFind in the treatment of Hypomelanotic Disorder. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Vitiligo, Hypomelanotic Disorder, Porphyria Cutanea Tarda, Melasma, and Thrombectomy. Dr. Pandya is board certified in Dermatology. Dr. Pandya is currently accepting new patients.

Elite in Hypomelanotic Disorder
Dr. Anuradha Bishnoi
Dermatology
Elite in Hypomelanotic Disorder
Dr. Anuradha Bishnoi
Dermatology
Referral may be required

UPMC North Hills Dermatology

9000 Brooktree Road, Suite 200, 
Wexford, PA 
724-933-1320
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Anuradha Bishnoi, MD, specializes in dermatology. She practices at UPMC North Hills Dermatology and UPMC Shadyside Dermatology. Dr. Bishnoi received her medical degree from Maharshi Dayanand University and completed her residency at the Postgraduate Institute of Medical Education and Research. Dr. Bishnoi is rated as an Elite provider by MediFind in the treatment of Hypomelanotic Disorder. She is also highly rated in 23 other conditions, according to our data. Her clinical expertise encompasses Hypomelanotic Disorder, Vitiligo, Lichen Planus, and Melasma. Dr. Bishnoi is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Hypomelanotic Disorder
Dr. John Harris
Dermatology
Elite in Hypomelanotic Disorder
Dr. John Harris
Dermatology
Referral may be required

Hahnemann Campus

281 Lincoln St, 
Worcester, MA 
508-334-5979
Languages Spoken:
English
See accepted insurances

John Harris is a Dermatologist practicing medicine in Worcester, Massachusetts. Dr. Harris is rated as an Elite provider by MediFind in the treatment of Hypomelanotic Disorder. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Vitiligo, Hypomelanotic Disorder, Cutaneous Lupus Erythematosus (CLE), and Bullae.

View All Doctors
What are the latest Hypomelanotic Disorder Clinical Trials?
Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Enrollment Status: Recruiting
Publish Date: June 18, 2026

Summary: Hermansky-Pudlak Syndrome (HPS) is an inherited disease which results in decreased pigmentation (oculocutaneous albinism), bleeding problems due to a platelet abnormality (platelet storage pool defect), and storage of an abnormal fat-protein compound (lysosomal accumulation of ceroid lipofuscin). The disease can cause poor functioning of the lungs, intestine, kidneys, or heart. The major complicat...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Zasocitinib in Participants With Nonsegmental Vitiligo
A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Trial to Evaluate the Efficacy and Safety of Zasocitinib in Participants With Nonsegmental Vitiligo
Enrollment Status: Recruiting
Publish Date: June 12, 2026
Intervention Type: Drug, Other
Study Phase: Phase 2

Summary: Vitiligo is a long-term autoimmune condition that causes the skin to lose its color. The body's germ-fighting system (immune system) mistakenly attacks the skin cells (melanocytes) which produce the pigment that gives the skin color (melanin). This leads to the formation of patches of skin with less or no pigment (depigmentation). These patches can occur anywhere on the body. In the nonsegmental f...

View All Clinical Trials